Zydus cadila animal health business sold to multiples alternate asset management-led consortium

INDIA – Cadila healthcare and its wholly-owned subsidiary Zydus Animal Health and Investment has completed sale of its animal healthcare established markets undertaking to Multiples Alternate Asset Management-led consortium for (US$391,667) Rs 2,921 crore. Zydus Animal Health and Investment entered into a definitive pact for sale of its animal healthcare established markets undertaking to Multiples Alternate Asset Management-led consortium. This deal involves transfer of immovable assets, movable assets, inventory, brands and intangible assets, contracts, licenses and permissions, business records, employees along with employee benefit funds, insurance policies, other assets and…

Read More

CribMD acquires Charisland Pharmaceuticals to facilitate enhanced drug deliveries

NIGERIA – CribMD, a Nigerian healthtech startup, has announced its acquisition of Charisland Pharmaceuticals Group to ensure fast and efficient drug deliveries to its customers across Nigeria. Charisland Pharmaceuticals Group was founded nine years ago and has a presence in major Nigerian cities. With the Group’s decision to exit the Nigerian market and expand into Canada, CribMD’s acquisition of the pharmaceutical chain, as opposed to building a solution in-house, will see it leverage the company’s vast network of pharmacies to deliver drugs faster to their subscribers. The acquisition comes on…

Read More

1MG now valued at US$450m after Tata group buys 51% of its stake

INDIA – IMG, an e-pharmacy retailer incorporated in 2015 that also offers teleconsultation services and operates three diagnostics labs is now worth US$450million after Tata group buys 51% of its stake to become a majority shareholder. Tata group, is an Indian public multinational conglomerate manufacturer of automobiles, airplanes and with previous affiliation to the pharma industry bought stakes worth US$230million. The e-pharmacy venture, 1MG was valued at US$242 million and had already raised US$156 million worth of capital prior to Tata group’s mega investment with a recorded a loss of…

Read More

PharmEasy achieves US$1.8B valuation after B Capital’s investment

INDIA- PharmEasy, an e-commerce drug supply store is now valued at US$ 1.8B after B capital bought stakes worth US$ 20M of the company. Prior to the investment, Pharmeasy was valued at US$ 1.5billion and is among the few Indian startups that have been able to achieve a unicorn status. B capital, a multi-stage global venture capital firm, bought the stakes from Everstone Capital an Indian based investment company that decided to sell part of the PharmEasy stakes. Earlier this year, PharmEasy closed the acquisition of smaller rival Medlife and…

Read More

Brains Bioceutical secures US$ 31.9m from DSM venturing

CANADA – Royal DSM venturing a Dutch multinational corporation active in the fields of health, nutrition and materials has pumped US$ 31.9m worth of investment into Brains Bioceutical corporation during an investment round and capital raise. This major investment was made possible by Del Morgan & Co., an affiliate financial agent of Brains Bioceutical corporation. Brains is among the leading identifiable companies that heavily ventures into cannabinoid (CBD) as an Active Pharmaceutical Ingredient (API) through research, development, production and clinical trials. CBD, an active ingredient in cannabis is derived from…

Read More